{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:19:18Z","timestamp":1783693158756,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Korea Ministry of Trade Industry and Energy","doi-asserted-by":"publisher","award":["RS-2024-00434342"],"award-info":[{"award-number":["RS-2024-00434342"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002462","name":"Chungnam National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-25397599"],"award-info":[{"award-number":["RS-2025-25397599"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2022-NR070856"],"award-info":[{"award-number":["RS-2022-NR070856"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00278597"],"award-info":[{"award-number":["RS-2023-00278597"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00460694"],"award-info":[{"award-number":["RS-2024-00460694"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003562","name":"Korea Ministry of Environment","doi-asserted-by":"publisher","award":["RS-2021-KE001333"],"award-info":[{"award-number":["RS-2021-KE001333"]}],"id":[{"id":"10.13039\/501100003562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003654","name":"Korea Environmental Industry and Technology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","award":["26212MFDS008"],"award-info":[{"award-number":["26212MFDS008"]}],"id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","award":["KK-2401-01"],"award-info":[{"award-number":["KK-2401-01"]}],"id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","award":["2710008763"],"award-info":[{"award-number":["2710008763"]}],"id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00336984"],"award-info":[{"award-number":["RS-2024-00336984"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02306055"],"award-info":[{"award-number":["RS-2025-02306055"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinthera.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:02:56Z","timestamp":1781640176000},"page":"691-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence-Based Exploration of Exposure-Matched Candidate Pirfenidone Dose for East Asian Populations based on Population Pharmacokinetic Modeling and Simulation Approach"],"prefix":"10.1016","volume":"48","author":[{"given":"Seongwon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi-yeol","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-7063","authenticated-orcid":false,"given":"Jung-Woo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaeWoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.05.013_bib0001","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12890-023-02340-8","article-title":"Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0003","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5588\/ijtld.16.0402","article-title":"Health care burden and medical resource utilisation of idiopathic pulmonary fibrosis in Korea","volume":"21","author":"Kim","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0004","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40273-018-0631-8","article-title":"The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence review","volume":"36","author":"Diamantopoulos","year":"2018","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0006","doi-asserted-by":"crossref","first-page":"104694","DOI":"10.1016\/j.phrs.2020.104694","article-title":"Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence","volume":"155","author":"Aimo","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0007","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0008","first-page":"377","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pupt.2009.03.003","article-title":"Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults","volume":"22","author":"Rubino","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0012","unstructured":"U.S. Food and Drug Administration., \u201cApplication number: 022535Orig1s000, clinical pharmacology & biopharmaceutics reviews.\u201d Accessed August 01, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/022535Orig1s000toc.cfm"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0013","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/ajrccm.159.4.9805017","article-title":"Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study","volume":"159","author":"Raghu","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0014","article-title":"A case report: the efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease A CARE-compliant article","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0261684","article-title":"Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real-world study","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3904\/kjim.2020.559","article-title":"Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study","volume":"37","author":"Hwang","year":"2022","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0017","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000363064","article-title":"Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases","volume":"88","author":"Oltmanns","year":"2014","journal-title":"Respiration"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0018","first-page":"148","article-title":"A real-world study of the tolerability and dosing of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis: pirfenidone dose and survival in IPF. Sarcoidosis Vasc Diffuse Lung","volume":"37","author":"Dhooria","year":"2020","journal-title":"Dis"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0019","doi-asserted-by":"crossref","first-page":"21218","DOI":"10.1038\/s41598-020-77837-x","article-title":"Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital","volume":"10","author":"Song","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0020","article-title":"Factors associated with dose reduction of pirfenidone in patients with idiopathic pulmonary fibrosis: a study based on real-world clinical data","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/resp.13145","article-title":"Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia","volume":"23","author":"Uehara","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0022","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40262-023-01250-6","article-title":"Multicenter population pharmacokinetics and exposure\u2013efficacy analysis of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"62","author":"Wang","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05279","article-title":"Pharmacokinetic evaluation of two pirfenidone formulations in patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis","volume":"6","author":"Barranco-Gardu\u00f1o","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0033-1341478","article-title":"Pharmacokinetics, safety and tolerability of pirfenidone and its major metabolite after single and multiple oral doses in healthy Chinese subjects under fed conditions","volume":"63","author":"Huang","year":"2013","journal-title":"Drug Res"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/0091270007304104","article-title":"Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers","volume":"47","author":"Shi","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0026","doi-asserted-by":"crossref","first-page":"1025947","DOI":"10.3389\/fphar.2022.1025947","article-title":"Clinical outcomes of dose modification during pirfenidone treatment for IPF: a nationwide post-marketing surveillance study","volume":"13","author":"Kang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0027","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.resinv.2015.06.001","article-title":"All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis","volume":"53","author":"Ogura","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0028","doi-asserted-by":"crossref","DOI":"10.3402\/ecrj.v3.32608","article-title":"Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results","volume":"3","author":"Salih","year":"2016","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.clinthera.2026.05.013_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:02:51Z","timestamp":1783692171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0149291826001608"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.05.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-Based Exploration of Exposure-Matched Candidate Pirfenidone Dose for East Asian Populations based on Population Pharmacokinetic Modeling and Simulation Approach","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}